Pubblicazioni

IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

2021 - TRIALS

Mouraux, A.; Bloms-Funke, P.; Boesl, I.; Caspani, O.; Chapman, S. C.; Di Stefano, G.; Finnerup, N. B.; Garcia-Larrea, L.; Goetz, M.; Kostenko, A.; Pelz, B.; Pogatzki-Zahn, E.; Schubart, K.; Stouffs, A.; Truini, A.; Tracey, I.; Troconiz, I. F.; Van Niel, J.; Vela, J. M.; Vincent, K.; Vollert, J.; Wanigasekera, V.; Wittayer, M.; Phillips, K. G.; Treede, R. -D.